Breath test targets TB (tuberculosis)
This article was originally published in Clinica
A US team is developing an "electronic nose" for detecting tuberculosis (TB) from a breath sample. The portable device may provide instant results and cut the costs associated with the traditional TB skin test, which takes several days to produce a result, claim researchers from the Illinois Institute of Technology in Chicago.
You may also be interested in...
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.
As the US heads into a COVID-19 storm with grave concerns about the lack of face masks and respirators for health care workers, the FDA has further relaxed federal oversight for such products, giving more responsibility to employers
FDA made request after finding unacceptable levels of nitrosamine NDMA can form during storage above room temperature or beyond expiry. Forthcoming guidance on detecting impurities like nitrosamines in any drug will call for routine testing as well as a chemical risk assessment “to look at what is the probability of generating them.